124 related articles for article (PubMed ID: 26525919)
1. Colorectal multidisciplinary meeting audit to determine patient benefit.
Fernando C; Frizelle F; Wakeman C; Frampton C; Robinson B
ANZ J Surg; 2017 Nov; 87(11):E173-E177. PubMed ID: 26525919
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of a Bi-National Colorectal Cancer Audit to characterize stage II colon cancer patients who were offered adjuvant chemotherapy.
Cooper EA; Buxey KN; Maslen BJ; Muhlmann M
ANZ J Surg; 2020 Jun; 90(6):1136-1140. PubMed ID: 32072761
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer treated at Christchurch Hospital, New Zealand: a comparison of 1993 and 1998 cohorts.
Robinson B; Frizelle F; Dickson M; Frampton C
N Z Med J; 2005 Feb; 118(1210):U1323. PubMed ID: 15776099
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting.
Rogers MJ; Matheson L; Garrard B; Maher B; Cowdery S; Luo W; Reed M; Riches S; Pitson G; Ashley DM
Public Health; 2017 Aug; 149():74-80. PubMed ID: 28575751
[TBL] [Abstract][Full Text] [Related]
5. [Integrated multidisciplinary treatment of colorectal neoplasms].
Procacciante F; Caciolo F; Diamantini G; Flati D; Pitasi F; Abilaliaj V; Covotta A; Banelli E; Di Seri M; Citone G
Chir Ital; 2009; 61(1):1-10. PubMed ID: 19391334
[TBL] [Abstract][Full Text] [Related]
6. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
7. Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment?
Nikolovski Z; Watters DAK; Stupart D; Guest GD
ANZ J Surg; 2017 Oct; 87(10):E112-E115. PubMed ID: 25913227
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer. Radiologic staging.
Thoeni RF
Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
[TBL] [Abstract][Full Text] [Related]
9. Screening vs. non-screening detected colorectal cancer: Differences in pre-therapeutic work up and treatment.
Saraste D; Martling A; Nilsson PJ; Blom J; Törnberg S; Janson M
J Med Screen; 2017 Jun; 24(2):69-74. PubMed ID: 27470598
[TBL] [Abstract][Full Text] [Related]
10. Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer.
Eglinton T; Luck A; Bartholomeusz D; Varghese R; Lawrence M
Colorectal Dis; 2010 Jul; 12(7):667-73. PubMed ID: 19486092
[TBL] [Abstract][Full Text] [Related]
11. [Colorectal cancer: what should be the management of primary tumour?].
Lelong B; Moutardier V; Delpero JR
Rev Prat; 2004 Jan; 54(2):155-66. PubMed ID: 15086058
[TBL] [Abstract][Full Text] [Related]
12. Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast-Enhanced CT.
Kunawudhi A; Sereeborwornthanasak K; Promteangtrong C; Siripongpreeda B; Vanprom S; Chotipanich C
Asian Pac J Cancer Prev; 2016; 17(8):4071-5. PubMed ID: 27644663
[TBL] [Abstract][Full Text] [Related]
13. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
14. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
Keating J; Yong D; Cutler G; Johnston J
N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
[TBL] [Abstract][Full Text] [Related]
16. Gynaecological cancer pathway for faster cancer treatment: a clinical audit.
Askew C; Gangji A
N Z Med J; 2016 Oct; 129(1444):79-89. PubMed ID: 27806031
[TBL] [Abstract][Full Text] [Related]
17. PET/CT in anal cancer - is it worth doing?
Wells IT; Fox BM
Clin Radiol; 2012 Jun; 67(6):535-40. PubMed ID: 22208962
[TBL] [Abstract][Full Text] [Related]
18. Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?
McBrearty A; McCallion K; Moorehead RJ; McAllister I; Mulholland K; Gilliland R; Campbell WJ
Ulster Med J; 2016 Sep; 85(3):178-181. PubMed ID: 27698520
[TBL] [Abstract][Full Text] [Related]
19. EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review.
Tudyka V; Blomqvist L; Beets-Tan RG; Boelens PG; Valentini V; van de Velde CJ; Dieguez A; Brown G
Eur J Surg Oncol; 2014 Apr; 40(4):469-75. PubMed ID: 24439446
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer.
Kwon HY; Kim IK; Kang J; Sohn SK; Lee KY
Cancer Res Treat; 2016 Jul; 48(3):970-7. PubMed ID: 26511802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
